CINCINNATI, May 17 /PRNewswire-FirstCall/ -- Kendle , a leading, global full-service clinical research organization (CRO), today announced the promotion of Patricia A. Steigerwald, MS, RN to Vice President, Global Late Phase. In this role she will provide executive leadership responsibility to drive continued growth in Kendle’s Late Phase brand globally, with a focus on the design and conduct of Phase IIIB/IV clinical trials, health economics and outcomes research and product/disease registries.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
“Phase IIIB/IV continues to be an area of significant customer need, with the global outsourcing market estimated to reach $4.7 to $4.8 billion by 2010,” said Kendle Chairman and Chief Executive Officer Dr. Candace Kendle, PharmD. “Pat’s expertise in the strategic and operational design and execution of large clinical endpoint trials will further position Kendle to capitalize on this exciting and growing marketing opportunity in the global late phase market.”
Steigerwald most recently was Senior Director, Late Phase for Kendle and brings more than 20 years of CRO and clinical experience to this new position. Prior to joining Kendle she spent seven years with a leading CRO in a variety of positions in the late stage trials division, serving most recently as Executive Director. In this position, she had overall responsibility for the strategic direction of the division and the development of goals, systems and procedures to ensure timely delivery of Phase IIIB/IV trials. Her experience also includes providing strategic guidance and oversight in the conduct of one of the world’s largest global cardiovascular medical outcomes trials ever conducted. Steigerwald also served as Nursing Director, Inpatient Oncology and General Medicine/ Pulmonary Care Units at New Hanover Regional Medical Center. Her therapeutic background in oncology also includes a variety of studies involving melanoma, small cell lung cancer and colon cancer.
Steigerwald earned a Master of Science in health science/allied health and a Bachelor of Science in nursing from Slippery Rock University (Pennsylvania). She is a member of the Sigma Theta Tau Nursing Honor Society and the Oncology Nursing Society and has served as an adjunct faculty member for Cape Fear Community College School of Nursing and the University of North Carolina, Wilmington School of Nursing.
Kendle’s Late Phase brand assists biopharmaceutical companies worldwide in maximizing market penetration and brand share during late phase product development and commercialization. The group currently manages more pregnancy registries than any other CRO, including the oldest and largest pregnancy registry ever conducted with more than 10,000 patients from 1,700 sites across 51 countries.
About Kendle
Kendle International Inc. is among the world’s leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world’s biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company’s Web site at www.kendle.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Investors, Patty Frank, +1-513-763-1992, or Media, Lori Dorer,+1-513-345-1685, both of Kendle International Inc.
Web site: http://www.kendle.com/
